Voriconazole: review of a broad spectrum triazole antifungal agent

被引:29
|
作者
Kofla, G [1 ]
Ruhnke, M [1 ]
机构
[1] Humboldt Univ, Dept Med 2, Div Hematol Oncol, Charite, Berlin, Germany
关键词
antifungal agent; azole; mould; mycoses; treatment; voriconazole;
D O I
10.1517/14656566.6.7.1215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Voriconazole is a second-generation triazole antifungal agent, structurally derived from fluconazole with an extended spectrum of activity against a wide variety of yeasts and moulds. Developed for the treatment of life-threatening fungal infections, it appears to be an effective therapy option for invasive aspergillosis, fluconazole-resistant candidiasis and refractory or less-common invasive fungal infections. It is available for both oral and intravenous administration and is characterised by an acceptable safety and tolerability spectrum.
引用
收藏
页码:1215 / 1229
页数:15
相关论文
共 50 条
  • [31] Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on Iodiconazole
    Sun, Yixiang
    Zhang, Jiachen
    Liu, Rui
    Gao, Zixuan
    Wu, Xudong
    Liu, Nian
    Zhang, Haoyu
    Li, Kejian
    Luo, Zirui
    Liu, Rongrong
    Qin, Qiaohua
    Yin, Wenbo
    Su, Xin
    Zhao, Dongmei
    Cheng, Maosheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [32] Discovery of a Novel Broad-Spectrum Antifungal Agent Derived from Albaconazole
    Guillon, Remi
    Pagniez, Fabrice
    Picot, Carine
    Hedou, Damien
    Tonnerre, Alain
    Chosson, Elizabeth
    Duflos, Muriel
    Besson, Thierry
    Loge, Cedric
    Le Pape, Patrice
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 288 - 292
  • [33] FOCUS ON ITRACONAZOLE - A BROAD-SPECTRUM ANTIFUNGAL AGENT FOR TREATMENT OF BLASTOMYCOSIS AND HISTOPLASMOSIS
    SYMONDS, WT
    OCONNOR, G
    NIX, DE
    HOSPITAL FORMULARY, 1993, 28 (01): : 23 - &
  • [34] Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole
    Gruen, Barbara
    Krautter, Stefanie
    Riedel, Klaus-Dieter
    Mikus, Gerd
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (05) : 712 - 720
  • [35] Voriconazole: How to Use This Antifungal Agent and What to Expect
    Malani, Anurag N.
    Kerr, Lisa E.
    Kauffman, Carol A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (05) : 786 - 795
  • [36] TREATMENT OF MURINE PULMONARY MUCORMYCOSIS WITH SCH-42427, A BROAD-SPECTRUM TRIAZOLE ANTIFUNGAL DRUG
    GOLDANI, LZ
    SUGAR, AM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 369 - 372
  • [37] Polymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent
    Qian, Jian
    Wiederhold, Nathan P.
    Patterson, Thomas
    Patterson, Hoja
    Berkland, Cory J.
    ACS APPLIED POLYMER MATERIALS, 2021, 3 (12) : 6034 - 6039
  • [38] Brevibacillus brevis -: a novel candidate biocontrol agent with broad-spectrum antifungal activity
    Seddon, B
    McHugh, RC
    Schmitt, A
    BCPC CONFERENCE: PESTS & DISEASES 2000, VOLS 1-3, PROCEEDINGS, 2000, 1-3 : 563 - 570
  • [39] Synthesis of Isomeric and Potent Impurities of the Triazole-Based Antifungal Drug Voriconazole
    Sundaram, Dhanraj T. S. S.
    Mitra, Jayati
    Islam, Aminul
    Prabahar, Koilpillai Joseph
    Rao, Battula Venkateswara
    Douglas, Sanasi Paul
    SCIENTIA PHARMACEUTICA, 2015, 83 (03) : 445 - 452
  • [40] Pharmacokinetics, Tissue Concentrations, and Safety of the Antifungal Agent Voriconazole in Chickens
    Burhenne, Juergen
    Haefeli, Walter E.
    Hess, Michael
    Scope, Alexandra
    JOURNAL OF AVIAN MEDICINE AND SURGERY, 2008, 22 (03) : 199 - 207